The Healthtech Podcast

Dr. Peter Kecskemethy is a serial entrepreneur and the CEO/co-founder of Kheiron Medical, an AI cancer diagnostics company based in London. He is a computer scientist by background and prior to Kheiron, he founded two tech start-ups and was lead developer in two others. Peter did his PhD and post-doctoral research at the University of Oxford in high performance computing and computational statistics for population genetics. Kheiron’s mission is to give a better fighting chance against cancer and its current focus is breast screening. The company’s first product, Mia, has European regulatory approval, and won best new radiology solution for 2019.
https://www.kheironmed.com/ | https://www.linkedin.com/in/kecsky/
Get in touch:
www.jamessomauroo.com | www.somx.co.uk

For this week's Sunday Session, we have a clip of James on the Virti Human Performance Podcast talking about what he and the team at somX do to build brand for healthtech companies, get their messaging on-point and how they think about content generation to specific audiences in healthcare. Whether you're building your personal brand or your healthtech company's brand, this one is worth a listen!
Listen to the full episode on the Virti Human Performance Podcast:
https://podcasts.apple.com/gb/podcast/the-human-performance-podcast/id1498467993?i=1000493127643
Join the waiting list for somX:
www.somx.co.uk
Get in touch:
www.jamessomauroo.com

This week, James is joined by Rob Walton, the president and CEO of GE Healthcare's businesses in 13 markets across Southeast Asia, Korea, Australia and New Zealand. He took on the role in June 2019 and is responsible for leading all the business activities for GE healthcare in the region.
https://www.linkedin.com/in/rob-walton-511555/ | https://www.gehealthcare.co.uk/ Get in touch:

www.jamessomauroo.com | www.somx.co.uk

Tomer is a Partner & CFO at aMoon, where he leads mid-late stage investments in healthtech companies. Tomer joined aMoon in early 2018 and led several investments including $30M Series C round in Zebra Medical Vision and $55M Series D round in Seer. He is also a board member in PharmaTwoB and Mapi. With 15 years of US capital markets experience, Tomer spearheads aMoon’s Bridge to Wall Street, where he manages the fund’s relationships with major investment banks, equity research analysts and investment funds.
Prior to joining aMoon, Tomer was the CFO & COO of Alcobra, a NASDAQ-listed development-stage biotech company, where he led successful public equity offerings from leading US healthcare funds. Prior to joining Alcobra, he was an Executive Director in J.P. Morgan’s Investment Banking Division in New York, where he played a leading role in numerous capital market and mergers and acquisitions transactions. In this capacity, he advised senior management and boards of directors of J.P. Morgan's key U.S. clients, including several S&P 500 healthcare firms. Prior to joining J.P. Morgan, Tomer worked in Citigroup's Investment Bank in New York. From 2000 to 2003, he served as an economist in the Financial Advisory Unit to the Chief of Staff of the Israel Defense Forces.
Tomer holds a Ph.D. in Finance and Economics (with Distinction) from Columbia Business School and has published a number of corporate finance articles in leading academic and practitioner journals. He also holds an M.Sc. in Finance and Accounting (Magna Cum Laude) and a B.A. in Economics and Management (Magna Cum Laude), both from Tel-Aviv University.
https://www.linkedin.com/in/tomerberkovitz/ | https://www.amoon.fund/
Get in touch:
www.jamessomauroo.com | www.somx.co.uk

Dr Owain Rhys Hughes is the founder and CEO of Cinapsis. He has over 13 years of experience working as a doctor and he is a Fellow of the Royal College of Surgeons. He has been awarded a personal Fellowship from the Medical Research Council and has twice received the British Journal of Surgery Prize.
Cinapsis SmartReferrals reduces A&E attendances by 83% and face-to-face appointments by 70% through advice & guidance. GPs can contact specialists for advice quickly and securely. Cinapsis SmartReferrals makes it very easy for primary care physicians, nurses, paramedics and pharmacists to talk directly and securely with local specialists. Specialists direct patient flow and improve efficiency by controlling when and where they see patients. Cinapsis SmartReferrals has been designed with consultants to help them work efficiently and without disruption.
https://www.linkedin.com/in/owainrhyshughes/ | https://www.cinapsis.org/
Get in touch:
www.jamessomauroo.com | www.somx.co.uk